BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16724487)

  • 1. Testing for crossover of two hazard functions using Gail and Simon's method.
    Chen YH; Liu GH
    J Biopharm Stat; 2006 May; 16(3):313-26. PubMed ID: 16724487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative risk estimation and inference using a generalized logrank statistic.
    Mehrotra DV; Roth AJ
    Stat Med; 2001 Jul; 20(14):2099-113. PubMed ID: 11439424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polynomial spline estimation and inference of proportional hazards regression models with flexible relative risk form.
    Huang JZ; Liu L
    Biometrics; 2006 Sep; 62(3):793-802. PubMed ID: 16984322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Monte Carlo approach for change-point detection in the Cox proportional hazards model.
    Liu M; Lu W; Shao Y
    Stat Med; 2008 Aug; 27(19):3894-909. PubMed ID: 18254131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Under-smoothed kernel confidence intervals for the hazard ratio based on censored data.
    Tu D
    Biom J; 2007 Jun; 49(3):474-83. PubMed ID: 17623350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim analysis on survival data: its potential bias and how to repair it.
    van Houwelingen HC; van de Velde CJ; Stijnen T
    Stat Med; 2005 Sep; 24(18):2823-35. PubMed ID: 16025546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible approach to the crossing hazards problem.
    Muggeo VM; Tagliavia M
    Stat Med; 2010 Aug; 29(18):1947-57. PubMed ID: 20680987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tests for treatment group differences in the hazards for survival, before and after the occurrence of an intermediate event.
    Bebchuk JD; Betensky RA
    Stat Med; 2005 Feb; 24(3):359-78. PubMed ID: 15568187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexible modeling of the effects of continuous prognostic factors in relative survival.
    Mahboubi A; Abrahamowicz M; Giorgi R; Binquet C; Bonithon-Kopp C; Quantin C
    Stat Med; 2011 May; 30(12):1351-65. PubMed ID: 21432891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating survival times to simulate Cox proportional hazards models.
    Bender R; Augustin T; Blettner M
    Stat Med; 2005 Jun; 24(11):1713-23. PubMed ID: 15724232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
    Rondeau V; Michiels S; Liquet B; Pignon JP
    Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dealing with the proportional hazards assumption when using the proportional hazards model with a single independent variable.
    Shibata A; Hamajima N; Tamakoshi A; Suzuki S; Sasaki R; Aoki K
    Jpn J Clin Oncol; 1989 Sep; 19(3):195-201. PubMed ID: 2810819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualitative interactions in multifactor studies.
    Russek-Cohen E; Simon RM
    Biometrics; 1993 Jun; 49(2):467-77. PubMed ID: 8369382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reformulating the hazard ratio to enhance communication with clinical investigators.
    Moser BK; McCann MH
    Clin Trials; 2008; 5(3):248-52. PubMed ID: 18559414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data.
    Moodie PF; Nelson NA; Koch GG
    Stat Med; 2004 Apr; 23(7):1075-93. PubMed ID: 15057879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for metastatic urothelial carcinoma treated with cisplatin and 5-fluorouracil-based regimens.
    Lin CC; Hsu CH; Huang CY; Tsai YC; Huang KH; Cheng AL; Pu YS
    Urology; 2007 Mar; 69(3):479-84. PubMed ID: 17382149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates--a simulation study.
    Jiang H; Symanowski J; Paul S; Qu Y; Zagar A; Hong S
    Stat Med; 2008 Dec; 27(28):5850-60. PubMed ID: 18759373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple test for independent censoring under the proportional hazards model.
    Lee SY; Wolfe RA
    Biometrics; 1998 Sep; 54(3):1176-82. PubMed ID: 9840972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-rank hazard regression for modelling non-proportional hazards.
    Perperoglou A; le Cessie S; van Houwelingen HC
    Stat Med; 2006 Aug; 25(16):2831-45. PubMed ID: 16158396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sequential testing approach to detecting multiple change points in the proportional hazards model.
    He P; Fang L; Su Z
    Stat Med; 2013 Mar; 32(7):1239-45. PubMed ID: 22933339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.